{
    "Trade/Device Name(s)": [
        "First Sign Multi-Drug Test Dip Card",
        "First Sign Multi-Drug Test Cup",
        "First Sign Multi-Drug Screen Test Dip Card",
        "First Sign Multi-Drug Screen Test Cup"
    ],
    "Submitter Information": "W.H.P.M., Inc.",
    "510(k) Number": "K210327",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182701"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QBF",
        "NGG",
        "NFY",
        "NFT",
        "NFW",
        "NFV",
        "NGL",
        "PTG",
        "LCM",
        "PTH",
        "QAW"
    ],
    "Summary Letter Date": "February 2, 2021",
    "Summary Letter Received Date": "February 4, 2021",
    "Submission Date": "August 10, 2021",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3150",
        "21CFR862.3170",
        "21CFR862.3250",
        "21CFR862.3620",
        "21CFR862.3610",
        "21CFR862.3650",
        "21CFR862.3700",
        "21CFR862.3910",
        "21CFR862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Benzodiazepine Test System",
        "Cocaine Test System",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Opiate Test System",
        "Propoxyphene Test System",
        "Tricyclic Antidepressant Drugs Test System",
        "Cannabinoids Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Buprenorphine",
        "Butalbital",
        "Oxazepam",
        "Cocaine",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "Propoxyphene",
        "Nortriptyline",
        "Marijuana"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunochemistry"
    ],
    "Submission Type(s)": [
        "Test",
        "Dip Card",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for First Sign Multi-Drug Test Dip Card, Cup, Screen Test Dip Card, and Screen Test Cup for qualitative detection of multiple drugs of abuse in human urine using lateral flow immunochromatographic assay.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of Amphetamine, Buprenorphine, Butalbital, Oxazepam, Cocaine, EDDP, Methamphetamine, MDMA, Morphine, Methadone, Oxycodone, Phencyclidine, Propoxyphene, Nortriptyline and Marijuana in human urine at defined cut-off concentrations; provides preliminary test results, requiring confirmation by an alternative chemical method.",
    "fda_folder": "Toxicology"
}